0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Gene Therapy Market Size, Status and Forecast 2019-2025
Published Date: March 2019
|
Report Code: QYRE-Othe-463
Home | Market Reports |Business & Industrial |Pharmaceuticals & Biotech
Global Cancer Gene Therapy Market Size Status and Forecast 2019 2025

Global Cancer Gene Therapy Market Size, Status and Forecast 2019-2025

Code: QYRE-Othe-463
Report
March 2019
97 Pages
QYResearch
Region: Global,
Description
Table of Content

Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
Americas will the major revenue contributor to this market due to the huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths in the region. The region’s focus on R&D has resulted in the emergence of several new treatment options that have long-term effect with minimum side effects.
In 2018, the global Cancer Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Gene Therapy development in United States, Europe and China.

The key players covered in this study
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene

Market segment by Type, the product can be split into
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy

Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Cancer Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Gene Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Gene Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Oncolytic Virotherapy
1.4.3 Gene Transfer
1.4.4 Gene-Induced Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Gene Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Gene Therapy Market Size
2.2 Cancer Gene Therapy Growth Trends by Regions
2.2.1 Cancer Gene Therapy Market Size by Regions (2014-2025)
2.2.2 Cancer Gene Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Gene Therapy Market Size by Manufacturers
3.1.1 Global Cancer Gene Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Gene Therapy Key Players Head office and Area Served
3.3 Key Players Cancer Gene Therapy Product/Solution/Service
3.4 Date of Enter into Cancer Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Gene Therapy Market Size by Type (2014-2019)
4.2 Global Cancer Gene Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Gene Therapy Market Size (2014-2019)
5.2 Cancer Gene Therapy Key Players in United States
5.3 United States Cancer Gene Therapy Market Size by Type
5.4 United States Cancer Gene Therapy Market Size by Application

6 Europe
6.1 Europe Cancer Gene Therapy Market Size (2014-2019)
6.2 Cancer Gene Therapy Key Players in Europe
6.3 Europe Cancer Gene Therapy Market Size by Type
6.4 Europe Cancer Gene Therapy Market Size by Application

7 China
7.1 China Cancer Gene Therapy Market Size (2014-2019)
7.2 Cancer Gene Therapy Key Players in China
7.3 China Cancer Gene Therapy Market Size by Type
7.4 China Cancer Gene Therapy Market Size by Application

8 Japan
8.1 Japan Cancer Gene Therapy Market Size (2014-2019)
8.2 Cancer Gene Therapy Key Players in Japan
8.3 Japan Cancer Gene Therapy Market Size by Type
8.4 Japan Cancer Gene Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Gene Therapy Market Size (2014-2019)
9.2 Cancer Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Cancer Gene Therapy Market Size by Type
9.4 Southeast Asia Cancer Gene Therapy Market Size by Application

10 India
10.1 India Cancer Gene Therapy Market Size (2014-2019)
10.2 Cancer Gene Therapy Key Players in India
10.3 India Cancer Gene Therapy Market Size by Type
10.4 India Cancer Gene Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Gene Therapy Market Size (2014-2019)
11.2 Cancer Gene Therapy Key Players in Central & South America
11.3 Central & South America Cancer Gene Therapy Market Size by Type
11.4 Central & South America Cancer Gene Therapy Market Size by Application

12 International Players Profiles
12.1 Adaptimmune
12.1.1 Adaptimmune Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Gene Therapy Introduction
12.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2014-2019)
12.1.5 Adaptimmune Recent Development
12.2 Bluebird bio
12.2.1 Bluebird bio Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Gene Therapy Introduction
12.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2014-2019)
12.2.5 Bluebird bio Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Gene Therapy Introduction
12.3.4 Celgene Revenue in Cancer Gene Therapy Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Shanghai Sunway Biotech
12.4.1 Shanghai Sunway Biotech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Gene Therapy Introduction
12.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2014-2019)
12.4.5 Shanghai Sunway Biotech Recent Development
12.5 Shenzhen SiBiono GeneTech
12.5.1 Shenzhen SiBiono GeneTech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Gene Therapy Introduction
12.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2014-2019)
12.5.5 Shenzhen SiBiono GeneTech Recent Development
12.6 SynerGene Therapeutics
12.6.1 SynerGene Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Gene Therapy Introduction
12.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2014-2019)
12.6.5 SynerGene Therapeutics Recent Development
12.7 Altor BioScience
12.7.1 Altor BioScience Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Gene Therapy Introduction
12.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2014-2019)
12.7.5 Altor BioScience Recent Development
12.8 Amgen
12.8.1 Amgen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Gene Therapy Introduction
12.8.4 Amgen Revenue in Cancer Gene Therapy Business (2014-2019)
12.8.5 Amgen Recent Development
12.9 Argenx
12.9.1 Argenx Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Gene Therapy Introduction
12.9.4 Argenx Revenue in Cancer Gene Therapy Business (2014-2019)
12.9.5 Argenx Recent Development
12.10 BioCancell
12.10.1 BioCancell Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Gene Therapy Introduction
12.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2014-2019)
12.10.5 BioCancell Recent Development
12.11 GlaxoSmithKline
12.12 Merck
12.13 OncoGenex Pharmaceuticals
12.14 Transgene

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
Americas will the major revenue contributor to this market due to the huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths in the region. The region’s focus on R&D has resulted in the emergence of several new treatment options that have long-term effect with minimum side effects.
In 2018, the global Cancer Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Gene Therapy development in United States, Europe and China.

The key players covered in this study
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene

Market segment by Type, the product can be split into
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy

Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Cancer Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Gene Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Read More

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Gene Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Oncolytic Virotherapy
1.4.3 Gene Transfer
1.4.4 Gene-Induced Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Gene Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Gene Therapy Market Size
2.2 Cancer Gene Therapy Growth Trends by Regions
2.2.1 Cancer Gene Therapy Market Size by Regions (2014-2025)
2.2.2 Cancer Gene Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Gene Therapy Market Size by Manufacturers
3.1.1 Global Cancer Gene Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Gene Therapy Key Players Head office and Area Served
3.3 Key Players Cancer Gene Therapy Product/Solution/Service
3.4 Date of Enter into Cancer Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Gene Therapy Market Size by Type (2014-2019)
4.2 Global Cancer Gene Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Gene Therapy Market Size (2014-2019)
5.2 Cancer Gene Therapy Key Players in United States
5.3 United States Cancer Gene Therapy Market Size by Type
5.4 United States Cancer Gene Therapy Market Size by Application

6 Europe
6.1 Europe Cancer Gene Therapy Market Size (2014-2019)
6.2 Cancer Gene Therapy Key Players in Europe
6.3 Europe Cancer Gene Therapy Market Size by Type
6.4 Europe Cancer Gene Therapy Market Size by Application

7 China
7.1 China Cancer Gene Therapy Market Size (2014-2019)
7.2 Cancer Gene Therapy Key Players in China
7.3 China Cancer Gene Therapy Market Size by Type
7.4 China Cancer Gene Therapy Market Size by Application

8 Japan
8.1 Japan Cancer Gene Therapy Market Size (2014-2019)
8.2 Cancer Gene Therapy Key Players in Japan
8.3 Japan Cancer Gene Therapy Market Size by Type
8.4 Japan Cancer Gene Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Gene Therapy Market Size (2014-2019)
9.2 Cancer Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Cancer Gene Therapy Market Size by Type
9.4 Southeast Asia Cancer Gene Therapy Market Size by Application

10 India
10.1 India Cancer Gene Therapy Market Size (2014-2019)
10.2 Cancer Gene Therapy Key Players in India
10.3 India Cancer Gene Therapy Market Size by Type
10.4 India Cancer Gene Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Gene Therapy Market Size (2014-2019)
11.2 Cancer Gene Therapy Key Players in Central & South America
11.3 Central & South America Cancer Gene Therapy Market Size by Type
11.4 Central & South America Cancer Gene Therapy Market Size by Application

12 International Players Profiles
12.1 Adaptimmune
12.1.1 Adaptimmune Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Gene Therapy Introduction
12.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2014-2019)
12.1.5 Adaptimmune Recent Development
12.2 Bluebird bio
12.2.1 Bluebird bio Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Gene Therapy Introduction
12.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2014-2019)
12.2.5 Bluebird bio Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Gene Therapy Introduction
12.3.4 Celgene Revenue in Cancer Gene Therapy Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Shanghai Sunway Biotech
12.4.1 Shanghai Sunway Biotech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Gene Therapy Introduction
12.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2014-2019)
12.4.5 Shanghai Sunway Biotech Recent Development
12.5 Shenzhen SiBiono GeneTech
12.5.1 Shenzhen SiBiono GeneTech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Gene Therapy Introduction
12.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2014-2019)
12.5.5 Shenzhen SiBiono GeneTech Recent Development
12.6 SynerGene Therapeutics
12.6.1 SynerGene Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Gene Therapy Introduction
12.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2014-2019)
12.6.5 SynerGene Therapeutics Recent Development
12.7 Altor BioScience
12.7.1 Altor BioScience Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Gene Therapy Introduction
12.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2014-2019)
12.7.5 Altor BioScience Recent Development
12.8 Amgen
12.8.1 Amgen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Gene Therapy Introduction
12.8.4 Amgen Revenue in Cancer Gene Therapy Business (2014-2019)
12.8.5 Amgen Recent Development
12.9 Argenx
12.9.1 Argenx Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Gene Therapy Introduction
12.9.4 Argenx Revenue in Cancer Gene Therapy Business (2014-2019)
12.9.5 Argenx Recent Development
12.10 BioCancell
12.10.1 BioCancell Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Gene Therapy Introduction
12.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2014-2019)
12.10.5 BioCancell Recent Development
12.11 GlaxoSmithKline
12.12 Merck
12.13 OncoGenex Pharmaceuticals
12.14 Transgene

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Enterprise License

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Generic Injection Market Size Status and Forecast 2021 2027
Global Generic Injection Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37X5172
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Bulk Pharmaceuticals Desiccant Bag Sales Market Report 2021
Global Bulk Pharmaceuticals Desiccant Bag Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-25M5205
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Glycerol Esters Sales Market Report 2021
Global Glycerol Esters Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-33D5109
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Bovine Fetuin Market Research Report 2021
Global Bovine Fetuin Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-16B5315
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0